Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 178

1.

A novel tetrameric gp350 1-470 as a potential Epstein-Barr virus vaccine.

Cui X, Cao Z, Sen G, Chattopadhyay G, Fuller DH, Fuller JT, Snapper DM, Snow AL, Mond JJ, Snapper CM.

Vaccine. 2013 Jun 26;31(30):3039-45. doi: 10.1016/j.vaccine.2013.04.071. Epub 2013 May 9.

2.

Novel synthetic (poly)glycerolphosphate-based antistaphylococcal conjugate vaccine.

Chen Q, Dintaman J, Lees A, Sen G, Schwartz D, Shirtliff ME, Park S, Lee JC, Mond JJ, Snapper CM.

Infect Immun. 2013 Jul;81(7):2554-61. doi: 10.1128/IAI.00271-13. Epub 2013 May 6.

3.

A randomized study of a monoclonal antibody (pagibaximab) to prevent staphylococcal sepsis.

Weisman LE, Thackray HM, Steinhorn RH, Walsh WF, Lassiter HA, Dhanireddy R, Brozanski BS, Palmer KG, Trautman MS, Escobedo M, Meissner HC, Sasidharan P, Fretz J, Kokai-Kun JF, Kramer WG, Fischer GW, Mond JJ.

Pediatrics. 2011 Aug;128(2):271-9. doi: 10.1542/peds.2010-3081. Epub 2011 Jul 25.

PMID:
21788224
4.

Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice.

Kokai-Kun JF, Chanturiya T, Mond JJ.

J Antimicrob Chemother. 2009 Jul;64(1):94-100. doi: 10.1093/jac/dkp145. Epub 2009 Apr 27.

PMID:
19398455
5.

Phase 1/2 double-blind, placebo-controlled, dose escalation, safety, and pharmacokinetic study of pagibaximab (BSYX-A110), an antistaphylococcal monoclonal antibody for the prevention of staphylococcal bloodstream infections, in very-low-birth-weight neonates.

Weisman LE, Thackray HM, Garcia-Prats JA, Nesin M, Schneider JH, Fretz J, Kokai-Kun JF, Mond JJ, Kramer WG, Fischer GW.

Antimicrob Agents Chemother. 2009 Jul;53(7):2879-86. doi: 10.1128/AAC.01565-08. Epub 2009 Apr 20.

6.

Safety and pharmacokinetics of a chimerized anti-lipoteichoic acid monoclonal antibody in healthy adults.

Weisman LE, Fischer GW, Thackray HM, Johnson KE, Schuman RF, Mandy GT, Stratton BE, Adams KM, Kramer WG, Mond JJ.

Int Immunopharmacol. 2009 May;9(5):639-44. doi: 10.1016/j.intimp.2009.02.008. Epub 2009 Mar 5.

PMID:
19268719
7.

Proliferative assays for B cell function.

Mond JJ, Brunswick M.

Curr Protoc Immunol. 2003 Nov;Chapter 3:Unit 3.10. doi: 10.1002/0471142735.im0310s57. Review.

PMID:
18432906
8.

In vitro antibody production.

Mond JJ, Brunswick M.

Curr Protoc Mol Biol. 2001 May;Chapter 11:Unit11.13. doi: 10.1002/0471142727.mb1113s50.

PMID:
18265070
9.

The multifunctional role of antibodies in the protective response to bacterial T cell-independent antigens.

Mond JJ, Kokai-Kun JF.

Curr Top Microbiol Immunol. 2008;319:17-40. Review.

PMID:
18080413
10.

The Staphylococcus aureus surface protein IsdA mediates resistance to innate defenses of human skin.

Clarke SR, Mohamed R, Bian L, Routh AF, Kokai-Kun JF, Mond JJ, Tarkowski A, Foster SJ.

Cell Host Microbe. 2007 May 17;1(3):199-212.

11.

Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model.

Kokai-Kun JF, Chanturiya T, Mond JJ.

J Antimicrob Chemother. 2007 Nov;60(5):1051-9. Epub 2007 Sep 10.

PMID:
17848374
12.

Characterization of IsaA and SceD, two putative lytic transglycosylases of Staphylococcus aureus.

Stapleton MR, Horsburgh MJ, Hayhurst EJ, Wright L, Jonsson IM, Tarkowski A, Kokai-Kun JF, Mond JJ, Foster SJ.

J Bacteriol. 2007 Oct;189(20):7316-25. Epub 2007 Aug 3.

13.
14.

Identification of antigenic components of Staphylococcus epidermidis expressed during human infection.

Pourmand MR, Clarke SR, Schuman RF, Mond JJ, Foster SJ.

Infect Immun. 2006 Aug;74(8):4644-54.

15.

Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage.

Clarke SR, Brummell KJ, Horsburgh MJ, McDowell PW, Mohamad SA, Stapleton MR, Acevedo J, Read RC, Day NP, Peacock SJ, Mond JJ, Kokai-Kun JF, Foster SJ.

J Infect Dis. 2006 Apr 15;193(8):1098-108. Epub 2006 Mar 13.

PMID:
16544250
16.

Correlates of the use of purging and non-purging methods of weight control in a community sample of women.

Mond JJ, Hay PJ, Rodgers B, Owen C, Mitchell J.

Aust N Z J Psychiatry. 2006 Feb;40(2):136-42.

PMID:
16476131
17.
18.

Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections.

Weidenmaier C, Kokai-Kun JF, Kristian SA, Chanturiya T, Kalbacher H, Gross M, Nicholson G, Neumeister B, Mond JJ, Peschel A.

Nat Med. 2004 Mar;10(3):243-5. Epub 2004 Feb 1.

PMID:
14758355
19.
20.

Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces.

Wu JA, Kusuma C, Mond JJ, Kokai-Kun JF.

Antimicrob Agents Chemother. 2003 Nov;47(11):3407-14.

21.

Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model.

Kokai-Kun JF, Walsh SM, Chanturiya T, Mond JJ.

Antimicrob Agents Chemother. 2003 May;47(5):1589-97.

22.

Distinct types of T-cell help for the induction of a humoral immune response to Streptococcus pneumoniae.

Snapper CM, Shen Y, Khan AQ, Colino J, Zelazowski P, Mond JJ, Gause WC, Wu ZQ.

Trends Immunol. 2001 Jun;22(6):308-11. Review.

PMID:
11377289
23.

B7 requirements for primary and secondary protein- and polysaccharide-specific Ig isotype responses to Streptococcus pneumoniae.

Wu ZQ, Khan AQ, Shen Y, Schartman J, Peach R, Lees A, Mond JJ, Gause WC, Snapper CM.

J Immunol. 2000 Dec 15;165(12):6840-8.

24.
25.
26.

Enhanced and sustained activation of human B cells by anti-immunoglobulin conjugated to the EBV glycoprotein gp350.

Goeckeritz BE, Lees A, Vos Q, Tsokos GC, Kuhlbusch K, Mond JJ.

Eur J Immunol. 2000 Mar;30(3):969-73.

28.

Modulation of B-lymphocyte and NK cell activities by glycoinositolphospholipid purified from Trypanosoma cruzi.

De Arruda Hinds LB, Previato LM, Previato JO, Vos Q, Mond JJ, Peçanha LM.

Infect Immun. 1999 Nov;67(11):6177-80.

29.

Multivalent cross-linking of membrane Ig sensitizes murine B cells to a broader spectrum of CpG-containing oligodeoxynucleotide motifs, including their methylated counterparts, for stimulation of proliferation and Ig secretion.

Goeckeritz BE, Flora M, Witherspoon K, Vos Q, Lees A, Dennis GJ, Pisetsky DS, Klinman DM, Snapper CM, Mond JJ.

Int Immunol. 1999 Oct;11(10):1693-700.

PMID:
10508187
30.

In vivo polysaccharide-specific IgG isotype responses to intact Streptococcus pneumoniae are T cell dependent and require CD40- and B7-ligand interactions.

Wu ZQ, Vos Q, Shen Y, Lees A, Wilson SR, Briles DE, Gause WC, Mond JJ, Snapper CM.

J Immunol. 1999 Jul 15;163(2):659-67.

31.

Heterogeneity in the ability of cytotoxic murine NK cell clones to enhance Ig secretion in vitro.

Vos Q, Snapper CM, Mond JJ.

Int Immunol. 1999 Feb;11(2):159-68.

PMID:
10069414
32.

Phenotypic and functional characterization of a panel of cytotoxic murine NK cell clones that are heterogeneous in their enhancement of Ig secretion in vitro.

Vos Q, Ortaldo JR, Conan-Cibotti M, Vos MD, Young HA, Anderson SK, Witherspoon K, Prager I, Snapper CM, Mond JJ.

Int Immunol. 1998 Aug;10(8):1093-101.

PMID:
9723695
33.

Characterization of early activation events in cord blood B cells after stimulation with T cell-independent activators.

Halista SM, Johnson-Robbins LA, El-Mohandes AE, Lees A, Mond JJ, Katona IM.

Pediatr Res. 1998 Apr;43(4 Pt 1):496-503.

PMID:
9545004
34.

Enhanced protective antibody responses to PspA after intranasal or subcutaneous injections of PspA genetically fused to granulocyte-macrophage colony-stimulating factor or interleukin-2.

Wortham C, Grinberg L, Kaslow DC, Briles DE, McDaniel LS, Lees A, Flora M, Snapper CM, Mond JJ.

Infect Immun. 1998 Apr;66(4):1513-20.

35.
36.

Restoration of T cell-independent type 2 induction of Ig secretion by neonatal B cells in vitro.

Snapper CM, Rosas FR, Moorman MA, Mond JJ.

J Immunol. 1997 Mar 15;158(6):2731-5.

PMID:
9058807
37.

Prospects for vaccines during pregnancy and in the newborn period.

Fischer GW, Ottolini MG, Mond JJ.

Clin Perinatol. 1997 Mar;24(1):231-49. Review.

PMID:
9099512
38.

The effect of linomide, an immunoregulator in experimental autoimmune diseases, on humoral antibody responses in mice.

Morecki S, Nabet C, Falk P, Fridkis-Hareli M, Pecht I, Mond JJ, Slavin S.

Autoimmunity. 1997;25(4):223-32.

PMID:
9344330
39.

A model for induction of T cell-independent humoral immunity in response to polysaccharide antigens.

Snapper CM, Mond JJ.

J Immunol. 1996 Sep 15;157(6):2229-33. Review.

PMID:
8805617
40.

IFN-gamma is a potent inducer of Ig secretion by sort-purified murine B cells activated through the mIg, but not the CD40, signaling pathway.

Snapper CM, Rosas F, Moorman MA, Jin L, Shanebeck K, Klinman DM, Kehry MR, Mond JJ, Maliszewski CR.

Int Immunol. 1996 Jun;8(6):877-85.

PMID:
8671677
41.

IL-10 selectively regulates murine Ig isotype switching.

Shparago N, Zelazowski P, Jin L, McIntyre TM, Stuber E, Peçanha LM, Kehry MR, Mond JJ, Max EE, Snapper CM.

Int Immunol. 1996 May;8(5):781-90.

PMID:
8671667
43.
44.

Bacterial lipoproteins may substitute for cytokines in the humoral immune response to T cell-independent type II antigens.

Snapper CM, Rosas FR, Jin L, Wortham C, Kehry MR, Mond JJ.

J Immunol. 1995 Dec 15;155(12):5582-9.

PMID:
7499841
45.

T cell independent antigens.

Mond JJ, Vos Q, Lees A, Snapper CM.

Curr Opin Immunol. 1995 Jun;7(3):349-54. Review.

PMID:
7546399
46.
48.

PKC activity and protein phosphorylation in regulation of sIg mediated B cell activation.

Lindsberg ML, Feuerstein N, Balapure AK, Mond JJ.

Scand J Immunol. 1995 Feb;41(2):194-201.

PMID:
7863266
50.

T cell-independent antigens type 2.

Mond JJ, Lees A, Snapper CM.

Annu Rev Immunol. 1995;13:655-92. Review.

PMID:
7612238

Supplemental Content

Support Center